查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1464795

分子診斷自動化市場：按類型、應用和最終用途分類 - 2024-2030 年全球預測

Automation in the Molecular Diagnostics Market by Type (Amplification Automation, Analysis Automation, Extraction Automation), Application (Blood Screening, Genetic Testing, Infectious Diseases), End-use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年分子診斷自動化市場規模為117.5億美元，預計2024年將達到135.4億美元，2030年將達到328.1億美元，複合年成長率為15.79%。

分子診斷中的自動化是指使用先進​​的技術和機械來執行複雜的實驗室測試，檢測和測量患者樣本（例如血液、唾液和組織）中是否存在遺傳物質（例如 DNA 和 RNA）。與需要大量體力和時間的傳統方法不同，自動化簡化了這些流程，使其更快、更準確，並且能夠同時處理大量測試。人們對個人化醫療保健和精準醫療的日益關注需要更有效率、更準確的診斷。此外，全球慢性病盛行率的不斷上升正在推動對自動化分子診斷設備的需求。醫療保健基礎設施和研究方面的各種政府計劃和資金正在支持這些技術的採用。然而，自動化技術的初步投資對於小型實驗室和機構來說是令人望而卻步的。此外，自動化技術的持續創新，例如高通量系統和人工智慧整合，將推動市場向前發展。整合人工智慧和機器學習以增強診斷中的資料分析和解釋為製造商提供了重大機會。

主要市場統計
基準年[2023] 117.5億美元
預測年份 [2024] 135.4億美元
預測年份 [2030] 328.1億美元
複合年成長率（%） 15.79%

高通量環境中擴增自動化的重要性日益增加

自動擴增涉及將遺傳物質（DNA 或 RNA）擴增至可檢測水平並創建多個副本的過程。這是識別病原體和基因突變的分子診斷以及任何需要大量遺傳物質進行分析的應用中的關鍵步驟。在需要一致、快速處理大量樣本的高通量環境中，例如在感染疾病爆發或大規模基因檢測中，自動化擴增尤其重要。自動分析涉及對擴增遺傳物質的自動解釋。這包括基於軟體的變異檢測、定量和突變識別分析。對於希望最大限度地減少資料解釋中的人為錯誤的實驗室以及需要快速週轉時間而不影響準確性的實驗室來說，自動化分析至關重要。萃取自動化是指從樣本中自動提取核酸 (DNA/RNA) 的過程，是大多數分子診斷通訊協定的第一步。這種類型的自動化確保了核酸的高純度和產量，對於後續診斷步驟的成功至關重要。分析後自動化包括自動化分析後資料管理，包括報告、資料儲存和結果通訊。這確保了診斷結果的準確和及時的傳達。分析前自動化包括在進行實際診斷測試之前對樣本進行標記、分類和準備。此步驟對於減少分析前錯誤並提高診斷流程的整體效率至關重要。

最終用途：研究機構更喜歡高度可自訂和可擴展的自動化解決方案。

臨床實驗室優先考慮高通量、準確性和最小錯誤率。自動化使得處理大量測試並獲得一致的結果成為可能，這在高要求的環境中至關重要。這些實驗室通常擁有廣泛的測試組合，需要靈活的自動化來處理不同類型的檢測和樣本。醫院需要支援快速週轉時間並且易於整合到現有醫院資訊系統中的自動化解決方案。其重點是即時檢測和快速適應各種測試需求的能力，包括緊急和常規診斷測試。在研究實驗室中，明顯需要分子診斷的自動化，重點在於彈性、擴充性和準確性。這些設施專注於實驗研究，需要能夠準確適應各種分析和實驗條件的設備。

區域洞察

美國和加拿大因其先進的醫療基礎設施、大量的研發投資以及較高的人均醫療支出而在美洲地區處於領先地位。這些國家的需求因對各種疾病（包括感染疾病、癌症和遺傳性疾病）更快、更準確的診斷測試的需求而成長。重點是整合資料管理系統和診斷設備，以簡化工作流程並改善患者治療結果。在醫療保健資金、嚴格的監管標準以及對先進診斷解決方案的高度認知的推動下，歐盟 (EU) 國家呈現出採用自動化分子診斷設備的強勁趨勢。歐盟的 Horizo​​​​n 2020 等舉措支持醫療保健領域的研究和創新，包括分子診斷，從而促進新技術和系統的開發。在中東，在沙烏地阿拉伯和阿拉伯聯合大公國等國家大規模醫療投資的推動下，先進醫療技術的採用正在增加。包括中國、日本和印度在內的亞太地區在自動化分子診斷設備的採用方面顯示出顯著成長。這一成長的主要驅動力是醫療保健支出的增加、對疾病早期發現的認知以及政府改善醫療保健的努力。

FPNV定位矩陣

FPNV 定位矩陣對於評估分子診斷自動化市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對分子診斷自動化市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1. 分子診斷自動化市場的市場規模與預測為何？

2.分子診斷自動化市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3.分子診斷自動化市場的技術趨勢和法規結構是什麼？

4.分子診斷自動化市場主要廠商的市場佔有率為何？

5. 進入分子診斷自動化市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 日益關注個人化醫療保健和精準醫療
      • 世界各地慢性病發生率上升
      • 對照護現場診斷的需求不斷成長
    • 抑制因素
      • 與自動化技術相關的高初始投資
    • 機會
      • 高通量系統和人工智慧整合等自動化技術持續創新
      • 醫療保健基礎設施和研究方面的政府計劃和資金
    • 任務
      • 嚴格的核准流程規定
  • 市場區隔分析
    • 類型：擴增自動化在高通量環境中的重要性日益增加
    • 最終用途：研究機構更喜歡高度可自訂和可擴展的自動化解決方案
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章分子診斷自動化市場：按類型

  • 擴增自動化
  • 分析自動化
  • 萃取自動化
  • 後分析自動化
  • 分析前自動化

第7章分子診斷自動化市場：依應用分類

  • 驗血
  • 基因檢測
  • 感染疾病
  • 腫瘤學

第8章分子診斷自動化市場：依最終用途分類

  • 臨床實驗室
  • 醫院
  • 調查機構

第9章美洲分子診斷自動化市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區分子診斷自動化市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲分子診斷自動化市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Biocare 醫療和分子測量儀器合作改進生物成像成像技術
    • 推出 LuminUltra 的 BugCount Guardian 以增強工業微生物監測
    • Yourgene Health 宣布創新 MagBench 技術以增強非侵入性產前檢測
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-2D1F5C65740B

[193 Pages Report] The Automation in the Molecular Diagnostics Market size was estimated at USD 11.75 billion in 2023 and expected to reach USD 13.54 billion in 2024, at a CAGR 15.79% to reach USD 32.81 billion by 2030.

Automation in molecular diagnostics refers to the use of advanced technologies and machinery to perform complex laboratory tests that detect and measure the presence of genetic materials, including DNA and RNA, in a patient's sample, including blood, saliva, and tissue. Unlike traditional methods that require significant manual effort and time, automation streamlines these processes, making them faster, more accurate, and capable of handling a large volume of tests simultaneously. The rising focus on personalized healthcare and precision medicine necessitates more efficient and accurate diagnostics. Moreover, the increasing incidence of chronic diseases worldwide boosts the demand for automated molecular diagnostics. Various government programs and funding in healthcare infrastructure and research encourage the adoption of these technologies. However, the initial investment in automation technology can be prohibitive for smaller labs and institutions. Furthermore, continuous innovations in automation technology, such as high-throughput systems and AI integration, drive the market forward. Integrating AI and machine learning to enhance data analysis and interpretation in diagnostics poses significant opportunities for manufacturers.

KEY MARKET STATISTICS
Base Year [2023] USD 11.75 billion
Estimated Year [2024] USD 13.54 billion
Forecast Year [2030] USD 32.81 billion
CAGR (%) 15.79%

Type: Increasing significance of amplification automation in high-throughput settings

Amplification automation pertains to the process of amplifying & making multiple copies of the genetic material (DNA or RNA) to detectable levels. It is a crucial step in molecular diagnostics for identifying pathogens and genetic mutations and for any application requiring a significant quantity of genetic material for analysis. Amplification automation is particularly indispensable in high-throughput settings where a large number of samples need consistent and rapid processing, such as in infectious disease outbreaks or large-scale genetic testing. The automation segment of analysis involves the automated interpretation of amplified genetic material. This includes software-based analysis for variant detection, quantification, and mutation identification. Analysis automation is essential for laboratories aiming to minimize human error in data interpretation and those that require fast turnaround times without compromising accuracy. Extraction automation refers to the process of automatically extracting nucleic acids (DNA/RNA) from samples, which is the first step in most molecular diagnostic protocols. This type of automation ensures high purity and yield of nucleic acids, which is crucial for the success of subsequent diagnostic steps. Post-analytical automation involves the automated management of data post-analysis, including report generation, data storage, and result dissemination. This ensures accurate and timely communication of diagnostic results. Pre-analytical automation includes sample labeling, sorting, and preparation before the actual diagnostic tests are performed. This phase is essential for reducing pre-analytical errors and enhancing the overall efficiency of the diagnostic process.

End-use: Research institutions prefer highly customizable and scalable automation solutions

Clinical laboratories prioritize high throughput and accuracy with minimal error rates. Automation allows for the processing of a large volume of tests with consistent results, which is crucial in high-demand environments. These laboratories typically have a broader range of testing portfolios and require automation flexibility to handle various types of assays and samples. Hospitals require automation solutions that support rapid turnaround times and are easy to integrate into their existing hospital information systems. The focus is on point-of-care testing and the ability to quickly adapt to varied testing demands, including emergency and routine diagnostic tests. Research institutions have a distinct need for automation in molecular diagnostics, emphasizing flexibility, scalability, and precision. These establishments are focused on experimental research, requiring equipment that can accurately handle a wide variety of assays and experimental conditions.

Regional Insights

The United States and Canada are leading in the Americas region due to their advanced healthcare infrastructure, significant investment in research & development, and high healthcare expenditure per capita. The demand in these countries is accelerated by the need for quicker and more accurate diagnostic tests for a variety of diseases, including infectious diseases, cancer, and genetic disorders. There is a high emphasis on the integration of data management systems with diagnostic equipment to streamline workflows and improve patient outcomes. The European Union countries show a strong trend towards adopting automated molecular diagnostics, driven by the availability of healthcare funding, stringent regulatory standards, and a high degree of awareness about advanced diagnostic solutions. Initiatives such as the EU's Horizon 2020 have supported research and innovation in healthcare, including molecular diagnostics, leading to the development of new technologies and systems. The Middle East is experiencing growth in adopting advanced healthcare technologies due to substantial healthcare investments in countries including Saudi Arabia & UAE. The APAC region, encompassing countries including China, Japan, and India, has shown remarkable growth in the adoption of automated molecular diagnostics. The growth is primarily driven by rising healthcare expenditure and, awareness about early disease detection, and government initiatives towards healthcare improvement.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Automation in the Molecular Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Automation in the Molecular Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Automation in the Molecular Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adaltis S.r.l., altona Diagnostics GmbH, AstraGene, Becton, Dickinson and Company, Biocartis, bioMerieux S.A., Danaher Corporation, ELITech Group, F. Hoffmann-La Roche Ltd., Hologic, Inc., MEGAROBO technologies Co., Ltd., Meridian Bioscience, Molecular Devices, LLC, Mylab Discovery Solutions, QIAGEN N.V., QuidelOrtho Corporation, Revvity, Inc., Sansure Biotech Inc., Scispot.io Inc., Seegene, Inc., Siemens Healthineers AG, Tecan Group Ltd., The Festo Group, and Vela Diagnostics.

Market Segmentation & Coverage

This research report categorizes the Automation in the Molecular Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Amplification Automation
    • Analysis Automation
    • Extraction Automation
    • Post-analytical Automation
    • Pre-analytical Automation
  • Application
    • Blood Screening
    • Genetic Testing
    • Infectious Diseases
    • Oncology
  • End-use
    • Clinical Laboratories
    • Hospitals
    • Research Institutions
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Automation in the Molecular Diagnostics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Automation in the Molecular Diagnostics Market?

3. What are the technology trends and regulatory frameworks in the Automation in the Molecular Diagnostics Market?

4. What is the market share of the leading vendors in the Automation in the Molecular Diagnostics Market?

5. Which modes and strategic moves are suitable for entering the Automation in the Molecular Diagnostics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising focus on personalized healthcare and precision medicine
      • 5.1.1.2. Increasing incidence of chronic diseases across the globe
      • 5.1.1.3. Upsurge in the need for point of care diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. High initial investment associated with automation technology
    • 5.1.3. Opportunities
      • 5.1.3.1. Continuous innovations in automation technology including high-throughput systems and AI integration
      • 5.1.3.2. Government programs and funding in healthcare infrastructure and research
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations associated with the approval process
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing significance of amplification automation in high-throughput settings
    • 5.2.2. End-use: Research institutions prefer highly customizable and scalable automation solutions
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Automation in the Molecular Diagnostics Market, by Type

  • 6.1. Introduction
  • 6.2. Amplification Automation
  • 6.3. Analysis Automation
  • 6.4. Extraction Automation
  • 6.5. Post-analytical Automation
  • 6.6. Pre-analytical Automation

7. Automation in the Molecular Diagnostics Market, by Application

  • 7.1. Introduction
  • 7.2. Blood Screening
  • 7.3. Genetic Testing
  • 7.4. Infectious Diseases
  • 7.5. Oncology

8. Automation in the Molecular Diagnostics Market, by End-use

  • 8.1. Introduction
  • 8.2. Clinical Laboratories
  • 8.3. Hospitals
  • 8.4. Research Institutions

9. Americas Automation in the Molecular Diagnostics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Automation in the Molecular Diagnostics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Automation in the Molecular Diagnostics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Biocare Medical and Molecular Instruments Join Forces to Elevate Bioimaging Technologies
    • 12.3.2. The Launch of BugCount Guardian by LuminUltra to Enhnace Industrial Microbial Monitoring
    • 12.3.3. Yourgene Health Unveils Revolutionary MagBench Technology for Enhanced Non-Invasive Prenatal Testing
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET DYNAMICS
  • FIGURE 7. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION AUTOMATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION AUTOMATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ANALYSIS AUTOMATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ANALYSIS AUTOMATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY EXTRACTION AUTOMATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY EXTRACTION AUTOMATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY POST-ANALYTICAL AUTOMATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY POST-ANALYTICAL AUTOMATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRE-ANALYTICAL AUTOMATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRE-ANALYTICAL AUTOMATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD SCREENING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD SCREENING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 57. CANADA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. CANADA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 63. MEXICO AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. MEXICO AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. MEXICO AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. MEXICO AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. AUSTRALIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. AUSTRALIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 90. AUSTRALIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 91. CHINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. CHINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. CHINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. CHINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. CHINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 96. CHINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 97. INDIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. INDIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. INDIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. INDIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. INDIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 102. INDIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 103. INDONESIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. INDONESIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. INDONESIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. INDONESIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. INDONESIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 108. INDONESIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 109. JAPAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. JAPAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. JAPAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. JAPAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. JAPAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 114. JAPAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 115. MALAYSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. MALAYSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. MALAYSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. MALAYSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. MALAYSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 120. MALAYSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. PHILIPPINES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. PHILIPPINES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 126. PHILIPPINES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 127. SINGAPORE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. SINGAPORE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. SINGAPORE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. SINGAPORE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. SINGAPORE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 132. SINGAPORE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. SOUTH KOREA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. SOUTH KOREA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 138. SOUTH KOREA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 139. TAIWAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. TAIWAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. TAIWAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. TAIWAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. TAIWAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 144. TAIWAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 145. THAILAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. THAILAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. THAILAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. THAILAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. THAILAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 150. THAILAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 151. VIETNAM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. VIETNAM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. VIETNAM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. VIETNAM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. VIETNAM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 156. VIETNAM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 165. DENMARK AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. DENMARK AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. DENMARK AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. DENMARK AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. DENMARK AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 170. DENMARK AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 171. EGYPT AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. EGYPT AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. EGYPT AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. EGYPT AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. EGYPT AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 176. EGYPT AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 177. FINLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. FINLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. FINLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. FINLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. FINLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 182. FINLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 183. FRANCE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. FRANCE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. FRANCE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. FRANCE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. FRANCE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 188. FRANCE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 189. GERMANY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. GERMANY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. GERMANY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. GERMANY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. GERMANY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 194. GERMANY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 195. ISRAEL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. ISRAEL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. ISRAEL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 198. ISRAEL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 199. ISRAEL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 200. ISRAEL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 201. ITALY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. ITALY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. ITALY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. ITALY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. ITALY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 206. ITALY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. NETHERLANDS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. NETHERLANDS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 212. NETHERLANDS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 213. NIGERIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. NIGERIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. NIGERIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. NIGERIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. NIGERIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 218. NIGERIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 219. NORWAY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. NORWAY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. NORWAY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. NORWAY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. NORWAY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 224. NORWAY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 225. POLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. POLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. POLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. POLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. POLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 230. POLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 231. QATAR AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. QATAR AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. QATAR AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. QATAR AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. QATAR AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 236. QATAR AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 237. RUSSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. RUSSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. RUSSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 240. RUSSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 241. RUSSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 242. RUSSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. SAUDI ARABIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. SAUDI ARABIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 248. SAUDI ARABIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 255. SPAIN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SPAIN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SPAIN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. SPAIN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. SPAIN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 260. SPAIN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 261. SWEDEN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. SWEDEN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. SWEDEN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 264. SWEDEN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 265. SWEDEN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 266. SWEDEN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. SWITZERLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. SWITZERLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 272. SWITZERLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 273. TURKEY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. TURKEY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. TURKEY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. TURKEY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. TURKEY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 278. TURKEY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED KINGDOM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED KINGDOM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED KINGDOM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 291. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 292. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023